The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Radioimmunotherapy of human tumours
Open accessAbstract
The eradication of cancer remains a vexing problem despite recent advances in our understanding of the molecular basis of neoplasia. One therapeutic approach that has demonstrated potential involves the selective targeting of radionuclides to cancer-associated cell surface antigens using monoclonal antibodies. Such radioimmunotherapy (RIT) permits the delivery of a high dose of therapeutic radiation to cancer cells, while minimizing the exposure of normal cells. Although this approach has been investigated for several decades, the cumulative advances in cancer biology, antibody engineering and radiochemistry in the past decade have markedly enhanced the ability of RIT to produce durable remissions of multiple cancer types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tolerance of normal tissue to therapeutic irradiation
Emami, B., Lyman, J., Brown, A., Cola, L., Goitein, M., Munzenrider, J. E., Shank, B., Solin, L. J., & Wesson, M. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90171-y · Cited by 4,488
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,484
Scott, A. M., Wolchok, J. D., & Old, L. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3236 · Cited by 2,160
Radiobiology for the Radiologist
Fry, R. J. M., & Hall, E. J. (1995) · Radiation Research · doi:10.2307/3579017 · Cited by 1,337
Witzig, T. E., Gordon, L. I., Cabanillas, F., Czuczman, M. S., Emmanouilides, C., Joyce, R., Pohlman, B. L., Bartlett, N. L., Wiseman, G. A., Padre, N., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.076 · Cited by 1,170
131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma
Kaminski, M. S., Tuck, M., Estes, J., Kolstad, A., Ross, C. W., Zasadny, K., Regan, D., Kison, P., Fisher, S., Kroll, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041511 · Cited by 716
Witzig, T. E., Flinn, I. W., Gordon, L. I., Emmanouilides, C., Czuczman, M. S., Saleh, M. N., Cripe, L., Wiseman, G., Olejnik, T., Multani, P. S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.017 · Cited by 651
Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support
Press, O. W., Eary, J. F., Appelbaum, F. R., Martin, P. J., Badger, C. C., Nelp, W. B., Glenn, S., Butchko, G., Fisher, D., Porter, B., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310213291702 · Cited by 644
Self-citationCD20: a regulator of cell-cycle progression of B lymphocytes
Tedder, T. F., & Engel, P. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90276-3 · Cited by 590
Kaminski, M. S., Zelenetz, A. D., Press, O. W., Saleh, M., Leonard, J., Fehrenbacher, L., Lister, T. A., Stagg, R. J., Tidmarsh, G. F., Kroll, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.19.3918 · Cited by 584
Self-citationPhysiology of the CSF and Blood-Brain Barriers
Davson, H., & Segal, M. B. (1996) · Medical Entomology and Zoology · Cited by 582
Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) Antibody
Kaminski, M. S., Zasadny, K. R., Francis, I. R., Milik, A. W., Ross, C. W., Moon, S. D., Crawford, S. M., Burgess, J. M., Petry, N. A., Butchko, G. M., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308123290703 · Cited by 547
Relation between Effective Radiation Dose and Outcome of Radioiodine Therapy for Thyroid Cancer
Maxon, H. R., Thomas, S. R., Hertzberg, V. S., Kereiakes, J. G., Chen, I.-W., Sperling, M. I., & Saenger, E. L. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310203091601 · Cited by 503
Tumor therapy with targeted atomic nanogenerators.
McDevitt, M. R., Ma, D., Lai, L. T., Simon, J., Borchardt, P., Frank, R. K., Wu, K., Pellegrini, V., Curcio, M. J., Miederer, M., et al. (2001) · Science · doi:10.1126/science.1064126 · Cited by 501
Targeted α particle immunotherapy for myeloid leukemia
Jurcic, J. G., Larson, S. M., Sgouros, G., McDevitt, M. R., Finn, R. D., Divgi, C. R., Ballangrud, Å. M., Hamacher, K. A., Ma, D., Humm, J. L., et al. (2002) · Blood · doi:10.1182/blood.v100.4.1233.h81602001233_1233_1239 · Cited by 472
Self-citationMorschhauser, F., Radford, J., Van Hoof, A., Vitolo, U., Soubeyran, P., Tilly, H., Huijgens, P. C., Kolstad, A., d’Amore, F., Diaz, M. G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2015 · Cited by 460
First Clinical Experience with α-Emitting Radium-223 in the Treatment of Skeletal Metastases
Nilsson, S., Larsen, R. H., Fosså, S. D., Balteskard, L., Borch, K. W., Westlin, J.-E., Salberg, G., & Bruland, Ø. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2244 · Cited by 440
Press, O. W., Appelbaum, F., Martin, P. J., Matthews, D. C., Bernstein, I. D., Eary, J. F., Nelp, W. B., Gooley, T., Glenn, S., Porter, B., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92225-3 · Cited by 428
Self-citationZalutsky, M. R., Reardon, D. A., Akabani, G., Coleman, R. E., Friedman, A. H., Friedman, H. S., McLendon, R. E., Wong, T. Z., & Bigner, D. D. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.046938 · Cited by 410
Investigations of avidin and biotin for imaging applications.
Hnatowich, D. J., Virzi, F., & Rusckowski, M. (1987) · PubMed · Cited by 398
A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.
Fujimori, K., Covell, D. G., Fletcher, J. E., & Weinstein, J. N. (1990) · PubMed · Cited by 356
Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
Goldenberg, D. M., Sharkey, R. M., Paganelli, G., Barbet, J., & Chatal, J.-F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8471 · Cited by 351
Press, O. W., Eary, J. F., Gooley, T., Gopal, A. K., Liu, S., Rajendran, J. G., Maloney, D. G., Petersdorf, S., Bush, S. A., Durack, L. D., et al. (2000) · Blood · doi:10.1182/blood.v96.9.2934 · Cited by 325
Self-citationMatthews, D. C., Appelbaum, F. R., Eary, J. F., Fisher, D. R., Durack, L. D., Hui, T. E., Martin, P. J., Mitchell, D., Press, O. W., Storb, R., et al. (1999) · Blood · doi:10.1182/blood.v94.4.1237 · Cited by 312
Self-citationPress, O. W., Unger, J. M., Braziel, R. M., Maloney, D. G., Miller, T. P., LeBlanc, M., & Fisher, R. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.8198 · Cited by 280
Self-citationRosenblat, T. L., McDevitt, M. R., Mulford, D. A., Pandit-Taskar, N., Divgi, C. R., Panageas, K. S., Heaney, M. L., Chanel, S., Morgenstern, A., Sgouros, G., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0382 · Cited by 271
Self-citationXu, H., Cheung, I. Y., Guo, H.-F., & Cheung, N.-K. V. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4517 · Cited by 264
Self-citationCheung, N.-K. V., Cheung, I. Y., Kushner, B. H., Ostrovnaya, I., Chamberlain, E., Kramer, K., & Modak, S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.3807 · Cited by 263
Self-citationHorning, S. J., Younes, A., Jain, V., Kroll, S., Lucas, J., Podoloff, D., & Goris, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.040 · Cited by 258
Waldmann, T., White, J., Carrasquillo, J., Reynolds, J., Paik, C., Gansow, O., Brechbiel, M., Jaffe, E., Fleisher, T., & Goldman, C. (1995) · Blood · doi:10.1182/blood.v86.11.4063.bloodjournal86114063 · Cited by 249
Self-citationCompartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
Kramer, K., Kushner, B. H., Modak, S., Pandit-Taskar, N., Smith-Jones, P., Zanzonico, P., Humm, J. L., Xu, H., Wolden, S. L., Souweidane, M. M., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0038-7 · Cited by 247
Self-citationThree-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
Paganelli, G., Magnani, P., Zito, F., Villa, E., Sudati, F., Lopalco, L., Rossetti, C., Malcovati, M., Chiolerio, F., & Seccamani, E. (1991) · PubMed · Cited by 245
Fisher, R. I., Kaminski, M. S., Wahl, R. L., Knox, S. J., Zelenetz, A. D., Vose, J. M., Leonard, J. P., Kroll, S., Goldsmith, S. J., & Coleman, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.9217 · Cited by 240
Axworthy, D. B., Reno, J. M., Hylarides, M. D., Mallett, R. W., Theodore, L. J., Gustavson, L. M., Su, F.-M., Hobson, L. J., Beaumier, P. L., & Fritzberg, A. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1802 · Cited by 230
Scheinberg, D. A., Lovett, D., Divgi, C. R., Graham, M. C., Berman, E., Pentlow, K., Feirt, N., Finn, R. D., Clarkson, B. D., & Gee, T. S. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.3.478 · Cited by 224
The promise of targeted {alpha}-particle therapy.
Mulford, D. A., Scheinberg, D. A., & Jurcic, J. G. (2005) · PubMed · Cited by 223
Knox, S. J., Goris, M. L., Tempero, M. A., Weiden, P. L., Gentner, L., Breitz, H. B., Adams, G. P., Axworthy, D. B., Gaffigan, S., Bryan, K., et al. (2000) · PubMed · Cited by 212
Rossi, E. A., Goldenberg, D. M., Cardillo, T. M., McBride, W. J., Sharkey, R. M., & Chang, C.-H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600982103 · Cited by 209
Press, O. W., Shan, D., Howell-Clark, J., Eary, J. F., Appelbaum, F. R., Matthews, D. C., King, D. J., Haines, A. M. R., Hamann, P., Hinman, L. M., et al. (1996) · PubMed · Cited by 207
Self-citationMorschhauser, F., Radford, J., Van Hoof, A., Botto, B., Rohatiner, A. Z. S., Salles, G., Soubeyran, P., Tilly, H., Bischof-Delaloye, A., van Putten, W. L. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.6400 · Cited by 206
Nademanee, A., Forman, S., Molina, A., Fung, H., Smith, D., Dagis, A., Kwok, C., Yamauchi, D., Anderson, A.-L., Falk, P., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1310 · Cited by 201
Reardon, D. A., Akabani, G., Coleman, R. E., Friedman, A. H., Friedman, H. S., Herndon, J. E., McLendon, R. E., Pegram, C. N., Provenzale, J. M., Quinn, J. A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4082 · Cited by 197
Malaise, E. P., Fertil, B., Chavaudra, N., & Guichard, M. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90071-4 · Cited by 192
Pagel, J. M., Gooley, T. A., Rajendran, J., Fisher, D. R., Wilson, W. A., Sandmaier, B. M., Matthews, D. C., Deeg, H. J., Gopal, A. K., Martin, P. J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-213298 · Cited by 186
Self-citationRosen, S. T., Zimmer, A. M., Goldman-Leikin, R., Gordon, L. I., Kazikiewicz, J. M., Kaplan, E. H., Variakojis, D., Marder, R. J., Dykewicz, M. S., & Piergies, A. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.4.562 · Cited by 180
DeNardo, G. L., DeNardo, S. J., Goldstein, D. S., Kroger, L. A., Lamborn, K. R., Levy, N. B., McGahan, J. P., Salako, Q., Shen, S., & Lewis, J. P. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3246 · Cited by 180
Press, O. W., Unger, J. M., Rimsza, L. M., Friedberg, J. W., LeBlanc, M., Czuczman, M. S., Kaminski, M., Braziel, R. M., Spier, C., Gopal, A. K., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.4101 · Cited by 174
Self-citationPractical Theoretic Guidance for the Design of Tumor-Targeting Agents
Wittrup, K. D., Thurber, G. M., Schmidt, M. M., & Rhoden, J. J. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-396962-0.00010-0 · Cited by 171
Cancer radioimmunotherapy with alpha-emitting nuclides
Couturier, O., Supiot, S., Degraef-Mougin, M., Faivre-Chauvet, A., Carlier, T., Chatal, J.-F., Davodeau, F., & Cherel, M. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1803-2 · Cited by 170
Grana, C., Chinol, M., Robertson, C., Mazzetta, C., Bartolomei, M., De Cicco, C., Fiorenza, M., Gatti, M., Caliceti, P., & Paganelli, G. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600047 · Cited by 168
on behalf of the Membership of the International Cancer Imaging Society, Husband, J. E., Schwartz, L. H., Spencer, J., Ollivier, L., King, D. M., Johnson, R., & Reznek, R. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601843 · Cited by 161
Pagel, J. M., Appelbaum, F. R., Eary, J. F., Rajendran, J., Fisher, D. R., Gooley, T., Ruffner, K., Nemecek, E., Sickle, E., Durack, L., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2317 · Cited by 161
Self-citationLeonard, J. P., Coleman, M., Kostakoglu, L., Chadburn, A., Cesarman, E., Furman, R. R., Schuster, M. W., Niesvizky, R., Muss, D., Fiore, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.803 · Cited by 158
Forero, A., Weiden, P. L., Vose, J. M., Knox, S. J., LoBuglio, A. F., Hankins, J. H., Goris, M. L., Picozzi, V. J., Axworthy, D. B., Breitz, H. B., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3284 · Cited by 155
The Radioisotope Contributes Significantly to the Activity of Radioimmunotherapy
Davis, T. A., Kaminski, M. S., Leonard, J. P., Hsu, F. J., Wilkinson, M. J., Zelenetz, A. D., Wahl, R. L., Kroll, S., Coleman, M., Goris, M. L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0756 · Cited by 152
Press, O. W., Corcoran, M. C., Subbiah, K., Hamlin, D. K., Wilbur, D. S., Johnson, T., Theodore, L. J., Yau, E. K. C., Mallett, R. W., Meyer, D. L., et al. (2001) · Blood · doi:10.1182/blood.v98.8.2535 · Cited by 148
Self-citationCzuczman, M. S., Emmanouilides, C. E., Darif, M., Witzig, T. E., Gordon, L. I., Revell, S., Vo, K., & Molina, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2882 · Cited by 145
A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.
Schultz, J., Lin, Y., Sanderson, J., Zuo, Y., Stone, D. M., Mallett, R. W., Wilbert, S. M., & Axworthy, D. B. (2000) · PubMed · Cited by 127
Intralesional targeted alpha therapy for metastatic melanoma
Allen, B., Raja, C., Rizvi, S. M., Li, Y., Tsui, W., Graham, P., Thompson, J. A., Reisfeld, R. A., Kearsley, J. H., Morgenstern, A., et al. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.12.2251 · Cited by 124
Morschhauser, F., Kraeber‐Bodéré, F., Wegener, W. A., Harousseau, J., Petillon, M., Huglo, D. G., Trümper, L. H. P., Meller, J., Pfreundschuh, M. G., Kirsch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.7863 · Cited by 122
Miederer, M., McDevitt, M. R., Sgouros, G., Kramer, K., Cheung, N. V., & Scheinberg, D. A. (2004) · PubMed · Cited by 119
Self-citationRaja, C., Graham, P., Rizvi, S. M., Song, E. Y., Goldsmith, H., Thompson, J. F., Bosserhoff, A., Morgenstern, A., Apostolidis, C., Kearsley, J. H., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.6.4089 · Cited by 113
A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost
Reardon, D. A., Zalutsky, M. R., Akabani, G., Coleman, R. E., Friedman, A. H., Herndon, J. E., McLendon, R. E., Pegram, C. N., Quinn, J. A., Rich, J. N., et al. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-053 · Cited by 113
Preparation of alpha-emitting 213Bi-labeled antibody constructs for clinical use.
McDevitt, M. R., Finn, R. D., Ma, D., Larson, S. M., & Scheinberg, D. A. (1999) · PubMed · Cited by 112
Self-citationLarson, S. M., Pentlow, K. S., Volkow, N. D., Wolf, A. P., Finn, R. D., Lambrecht, R. M., Graham, M. C., Resta, G. D., Bendriem, B., & Daghighian, F. (1992) · PubMed · Cited by 111
Self-citationIntraperitoneal radio‐localization of tumors pre‐targeted by biotinylated monoclonal antibodies
Paganelli, G., Pervez, S., Siccardi, A. G., Rowlinson, G., Deleide, G., Chiolerio, F., Malcovati, M., Scassellati, G. A., & Epenetos, A. A. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450632 · Cited by 109
Zhang, M., Zhang, Z., Garmestani, K., Schultz, J., Axworthy, D. B., Goldman, C. K., Brechbiel, M. W., Carrasquillo, J. A., & Waldmann, T. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437788100 · Cited by 106
Self-citationKraeber‐Bodéré, F., Bardet, S., Hoefnagel, C. A., Vieira, M. R., Vuillez, J.-P., Murat, A., Ferreira, T. C., Bardiès, M., Ferrer, L., Resche, I., et al. (1999) · PubMed · Cited by 105
124I-huA33 Antibody PET of Colorectal Cancer
Carrasquillo, J. A., Pandit-Taskar, N. D., O’Donoghue, J. A., Humm, J. L., ZANZONICO, P. B., Smith-Jones, P. M., Divgi, C. R., Pryma, D. A., Ruan, S., Kemeny, N. E., et al. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.086165 · Cited by 103
Self-citationAntibodies with infinite affinity
Chmura, A. J., Orton, M. S., & Meares, C. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151260298 · Cited by 102
A modular IgG-scFv bispecific antibody topology
Orcutt, K. D., Ackerman, M. E., Cieslewicz, M., Quiroz, E., Slusarczyk, A. L., Frangioni, J. V., & Wittrup, K. D. (2009) · Protein Engineering Design and Selection · doi:10.1093/protein/gzp077 · Cited by 102
Winter, J. N., Inwards, D. J., SPIES, S. M., Wiseman, G. A., Patton, D. R., Erwin, W. D., RADEMAKER, A. W., Weitner, B. B., WILLIAMS, S. F., Tallman, M. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.2245 · Cited by 101
Intracellular catabolism of radiolabeled anti-mu antibodies by malignant B-cells.
Geissler, F. T., Anderson, S. K., Venkatesan, P., et al. (1992) · PubMed · Cited by 98
Pretargeting with the Affinity Enhancement System for Radioimmunotherapy
Barbet, J., Kraeber‐Bodéré, F., Vuillez, J.-P., Gautherot, E., Rouvier, É., & Chatal, J. (1999) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1999.14.153 · Cited by 96
A universal pretargeting system for cancer detection and therapy using bispecific antibody.
Sharkey, R. M., McBride, W. J., Karacay, H., Chang, K., Griffiths, G. L., Hansen, H. J., & Goldenberg, D. M. (2003) · PubMed · Cited by 94
Kenanova, V. E., Olafsen, T., Williams, L. E., Ruel, N. H., Longmate, J., Yazaki, P. J., Shively, J. E., Colcher, D. M., Raubitschek, A. A., & Wu, A. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-0454 · Cited by 94
Allen, B., Singla, A. A., Rizvi, S. M. A., Graham, P., Bruchertseifer, F., Apostolidis, C., & Morgenstern, A. (2011) · Immunotherapy · doi:10.2217/imt.11.97 · Cited by 93
Ocean, A. J., Pennington, K. L., Guarino, M. J., Sheikh, A., Bekaii‐Saab, T., Serafini, A. N., Lee, D. C., Sung, M. W., Güleç, S., Goldsmith, S. J., et al. (2012) · Cancer · doi:10.1002/cncr.27592 · Cited by 90
Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky, M. R., & Pozzi, O. R. (2004) · PubMed · Cited by 88
Chang, C., Rossi, E. A., & Goldenberg, D. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1217 · Cited by 85
GD2-Targeted Immunotherapy and Radioimmunotherapy
Dobrenkov, K., & Cheung, N. V. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.07.003 · Cited by 84
Self-citationAdvances in pretargeting biotechnology
Goodwin, D. A., & Meares, C. F. (2001) · Biotechnology Advances · doi:10.1016/s0734-9750(01)00065-9 · Cited by 81
Targeted cancer therapy with a novel low-dose rate α-emitting radioimmunoconjugate
Dahle, J., Borrebæk, J., Jónasdóttir, T. J., Hjelmerud, A. K., Melhus, K. B., Bruland, Ø. S., Press, O. W., & Larsen, R. H. (2007) · Blood · doi:10.1182/blood-2007-01-066803 · Cited by 80
Self-citationGautherot, E., Rouvier, É., Daniel, L., Loucif, E., Bouhou, J., Manetti, C., Martin, M., Doussal, J. M. L., & Barbet, J. (2000) · PubMed · Cited by 75
Devizzi, L. F., Guidetti, A., Tarella, C., Magni, M., Matteucci, P., Seregni, E. C., Chiesa, C., Bombardieri, E., Nicola, M. D., Carlo‐Stella, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.8294 · Cited by 72
Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque
Matthews, D., Appelbaum, F. R., Eary, J. F., Hui, T., Fisher, D., Martin, P., Durack, L. D., Nelp, W., Press, O. W., & Badger, C. C. (1991) · Blood · doi:10.1182/blood.v78.7.1864.1864 · Cited by 70
Self-citationSharkey, R. M., Press, O. W., & Goldenberg, D. M. (2009) · Blood · doi:10.1182/blood-2008-11-188896 · Cited by 69
Self-citationThe Promise of Targeted α-Particle Therapy
Mulford, D. A., Scheinberg, D. A., & Jurcic, J. G. (2005) · Journal of Nuclear Medicine · Cited by 67
Sharkey, R. M., Karacay, H., Johnson, C. R., Litwin, S., Rossi, E. A., McBride, W. J., Chang, C., & Goldenberg, D. M. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.058602 · Cited by 59
Pagel, J. M., Orgun, N. N., Hamlin, D. K., Wilbur, D. S., Gooley, T. A., Gopal, A. K., Park, S. I., Green, D. J., Lin, Y., & Press, O. W. (2009) · Blood · doi:10.1182/blood-2008-11-187401 · Cited by 56
Self-citationGoldenberg, D. M., Morschhauser, F., & Wegener, W. A. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428191003672123 · Cited by 56
Cheung, N. V., Modak, S. I., Lin, Y., Guo, H.-F., ZANZONICO, P. B., Chung, J., Zuo, Y., Sanderson, J., Wilbert, S. M., Theodore, L. J., et al. (2004) · PubMed · Cited by 56
Self-citationLink, B. K., Martin, P., Kaminski, M. S., Goldsmith, S. J., Coleman, M., & Leonard, J. P. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.8325 · Cited by 54
Radioimmunotherapy for non-Hodgkin's lymphomas: A historical perspective
Press, O. W. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)70053-0 · Cited by 51
Self-citationPagel, J. M., Lin, Y., Hedin, N., Pantelias, A., Axworthy, D. B., Stone, D. M., Hamlin, D. K., Wilbur, D. S., & Press, O. W. (2006) · Blood · doi:10.1182/blood-2005-11-4327 · Cited by 48
Self-citationZhang, M., Yao, Z., Zhang, Z., Garmestani, K., Talanov, V. S., Plascjak, P. S., Yu, S. G., Kim, H., Goldman, C. K., Paik, C. H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1189 · Cited by 47
Self-citationRadioimmunotherapy in Non-Hodgkin Lymphoma: Opinions of U.S. Medical Oncologists and Hematologists
Schaefer, N. G., Ma, J., Huang, P., Buchanan, J., & Wahl, R. L. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.073155 · Cited by 41
Johnson, T. A., & Press, O. W. (2000) · International Journal of Cancer · Cited by 35
Self-citationBiotin transport and metabolism in the central nervous system
Spector, R., & Mock, D. M. (1988) · Neurochemical Research · doi:10.1007/bf00971535 · Cited by 32
Pretargeted Radioimmunotherapy for Hematologic and Other Malignancies
Walter, R. B., Press, O. W., & Pagel, J. M. (2010) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2010.0759 · Cited by 31
Self-citationWitzig, T. E., Tomblyn, M. B., Misleh, J. G., Kio, E. A., Sharkey, R. M., Wegener, W. A., & Goldenberg, D. M. (2014) · Haematologica · doi:10.3324/haematol.2014.112110 · Cited by 31
Cyclooxygenase-2 inhibitors in colorectal cancer
Stoehlmacher, J., & Lenz, H. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00120-9 · Cited by 29
131I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma
Gopal, A. K., Pagel, J. M., Fromm, J. R., Wilbur, S. M., & Press, O. W. (2009) · Blood · doi:10.1182/blood-2009-02-205476 · Cited by 28
Self-citationGopal, A. K., Gooley, T. A., Rajendran, J. G., Pagel, J. M., Fisher, D. R., Maloney, D. G., Appelbaum, F. R., Cassaday, R. D., Shields, A. T., & Press, O. W. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.02.004 · Cited by 26
Self-citationSynthesis and in Vitro Characterization of a Dendrimer−MORF Conjugate for Amplification Pretargeting
Chen, X., Dou, S., Liu, G., Liu, X., Wang, Y., Chen, L., Rusckowski, M., & Hnatowich, D. J. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8001024 · Cited by 20
Liu, X., Wang, Y., Nakamura, K., Kubo, A., & Hnatowich, D. J. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701111 · Cited by 20
ABCs of Radioisotopes Used for Radioimmunotherapy: α- and β-Emitters
Waldmann, T. A. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001623685 · Cited by 17
Mones, J. V., Coleman, M., Kostakoğlu, L., et al. (2007) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190601059720 · Cited by 14
Press, O. W. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90054-4 · Cited by 12
Self-citation
Cited by
Development of therapeutic antibodies for the treatment of diseases
Lu, R.-M., Hwang, Y.-C., Liu, I.-J., Lee, C.-C., Tsai, H.-Z., Li, H.-J., & Wu, H.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0592-z · Cited by 2,085
Radiopharmaceutical therapy in cancer: clinical advances and challenges
Sgouros, G., Bodei, L., McDevitt, M. R., & Nedrow, J. R. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0073-9 · Cited by 963
CSF, blood-brain barrier, and brain drug delivery
Pardridge, W. M. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1171315 · Cited by 508
Chao, Y., Xu, L., Liang, C., Feng, L., Xu, J., Dong, Z., Tian, L., Yi, X., Yang, K., & Liu, Z. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0262-6 · Cited by 493
ImmunoPET: Concept, Design, and Applications
Wei, W., Rosenkrans, Z. T., Liu, J., Huang, G., Luo, Q.-Y., & Cai, W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00738 · Cited by 484
Metadata
- Authors
- Larson, S. M., Carrasquillo, J. A., Cheung, N.-K. V., & Press, O. W.
- Venue
- Nature Reviews Cancer
- Published
- 2015-05-22
- Volume
- 15
- Issue
- 6
- Pages
- 347-360
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1533229981
- Cited by
- 537
- References
- 110
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.